Rigel Pharmaceuticals (RIGL) Return on Capital Employed (QoQ) (2011 - 2026)
Rigel Pharmaceuticals (RIGL) Return on Capital Employed (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Rigel Pharmaceuticals | 681.25 Mn | 534.56 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,531.00 |
| Dec 31, 2025 | -4,634.00 |
| Sep 30, 2025 | -854.00 |
| Jun 30, 2025 | 5,737.00 |
| Mar 31, 2025 | 1,514.00 |
| Dec 31, 2024 | 1,543.00 |
| Sep 30, 2024 | 2,504.00 |
| Jun 30, 2024 | 1,716.00 |
| Mar 31, 2024 | 225.00 |
| Dec 31, 2023 | -252.00 |
| Sep 30, 2023 | 1,496.00 |
| Jun 30, 2023 | 540.00 |
| Mar 31, 2023 | 4,264.00 |
| Dec 31, 2022 | 1,305.00 |
| Sep 30, 2022 | -982.00 |
| Jun 30, 2022 | -1,488.00 |
| Mar 31, 2022 | -7,032.00 |
| Dec 31, 2021 | -367.00 |
| Sep 30, 2021 | -474.00 |
| Jun 30, 2021 | 480.00 |